Theme:

Dementia Conference 2021

Dementia Conference 2021

Conferenceseries LLC Ltd would like to announce its most awaited webinar “16th Annual Conference on Dementia and Alzheimers Disease”, scheduled on February 26, 2021 to explore best innovative research and development in dementia and alzheimers. On this note, we have taken the privilege to encourage neuro scientists, neurologists, neuroimaging Technicians, neuro Surgeon, neuropsychologists and exhibitors etc. to participate and showcase their unique researches to the global participants.

This webinar will cover up honorary keynote sessions, special session, Oral, poster, video presentation, E-poster, workshops, exhibitions by many academic experts from all around the world.

Abstract submission

“Dementia 2021” would like to call experts, Doctors, academic researchers and students to submit a brief note of their work as an abstract which must comprise of 150 to 350 words. Authors can choose the given scientific sessions while submitting the abstracts in the portal, new sessions are also welcome to be recommended by the speakers. . Participants can choose their type of presentation while submitting the abstract, i.e. Oral/Poster presentation.
(Please note that, only accepted abstracts will be published in the Dementia 2021 proceedings)

Submit Now

Early bird registration deadline

The early bird dates for the upcoming “16th Annual Conference on Dementia and Alzheimers Disease” is going to be closed on/ before 29th December 2020. For group participation and packages, reach us at "[email protected]".

Register Now

Please remember the following dates:

Abstract submission deadline: February 10th, 2021

Abstract acceptance duration: 24- 48 hrs

Registration deadline: February 20th, 2021

Who Attends:

  • Neuro surgeons
  • Neurologists
  • Psychologists
  • Neuropsychologist
  • Psychiatrists
  • Mental Health Psychiatrist
  • Psychiatric Technician
  • Psychiatric-Mental Health Nurse
  • Substance Abuse Nurse
  • Scientists and professors
  • Neuroimaging Technician
  • Students
  • Diagnostic laboratory professionals
  • Business Entrepreneurs
  • Industry professionals
  • Directors/Managers/CEO’s
  • Presidents & Vice Presidents

Track 1: Dementia

Dementia occurs as a set of symptoms occurred when the brain is damaged by disease. Dementia is not a disorder of consciousness that inhibit consciousness. This category generally involves minimally conscious state and persistent vegetative state. The earliest stage of dementia is called mild cognitive impairment like memory difficulty. In the initial stage of dementia, symptoms become detectable to others. In addition, the symptoms start to interfere with daily activities. Alzheimer's disease accounts for over 80% of cases of dementia. 

Track-2: Cognitive Therapies for Dementia

Psychological therapies for dementia involve some limited evidence for reminiscence therapy like positive effects in the areas of cognition, communication. Since dementia impairs normal communication because of the changes in receptive and expressive language, agitated behaviour is often a form of communication for the person with dementia. Actively searching for a potential cause, such as pain, physical illness, or overstimulation can be helpful in reducing agitation. 

Track-3:  Molecular Genetics and Biology of Dementia

Molecular biology investigation has significantly concentrated our understanding of the pathophysiological basis of Alzheimer's disease dementia. Distinguished progress has been generated in our understanding of the genetic science and biological science of dementedness. Some genetic risk factors are known to this point, however solely a low proportion of AD cases will be explained by specific sequence mutationsGenes can also be associated with sickness in 2 ways: through autosomal-dominant mutations, in themselves decent to cause the sickness as an alternative, factor variations (polymorphisms) could indirectly increase sickness risk while not being sufficient in themselves to cause the disorder.

Track-4: Neuroimaging Biomarker

Alzheimer's disease biomarkers with prominence on cerebrospinal fluid biomarkers and neuroimaging. Mild psychological feature Impairment (MCI) of Neuroimaging biomarkers enables an early designation in presymptomatic stages of Alzheimer’s sickness. Biomarker changes in patients with late-onset AD, Along with findings from studies mistreatment structural and practical resonance  imaging (MRI), advanced tomography techniques (diffusion tensor imaging, resonance qualitative analysis, perfusion)positron emission pictorial representation with fluorodeoxyglucose, amyloid tracers, and other neurochemical tracers and CSF protein levels.

Track 5: Alzheimer's Disease

Alzheimer's disease chronic neurodegenerative disease and destroy cerebrum cells, making thinking capacity and memory weaken. Alzheimer's infection is a degenerative, dynamic mind ailment and the most broadly recognized type of dementia and gathering of brain disorders that influence memory, considering and capacity to connect socially. Dementia and Alzheimer's infection are different from each other. Dementia is a general term used to depict indications that effect memory, mental ability execution of day by day exercises, and correspondence capacities. Regular physical activity, eating a healthy diet and keeping your brain active through lifelong learning can potentially improve outcomes.

Track-6: Neurodegenerative Diseases

Neurodegenerative sickness is paralysed, and it is a heterogeneous gathering of dislocation of serious conditions that outcome in dynamic degeneration. Neurodegenerative sickness cause issues with development called ataxias, or mental working called dementias. Neurodegenerative infections occur when nerve cells in the mind or fringe sensory system and may result in a loss of neurons and axons. Although medicines may help decline a portion of the physical or mental side effects related with neurodegenerative infections, As of now there is no cure or approach to moderate ailment movement. The danger of  neurodegenerative disease in the central nervous system drastically increase with age.

Track-7: Neurological Disorders

Neurological disorders are the disorders of the focal and fringe sensory system. At the end cranial nerves, fringe nerves, nerve roots, autonomic sensory system and neuromuscular intersection dilocation incorporate epilepsy, Alzheimer illness and different dementias, cerebrovascular sicknesses including stroke, headache and other various sclerosis, Parkinson's disease, neuroinfectious, brain tumors, dreadful scatters of the sensory system because of head injury, and neurological issue due to hunger. Neurological symptoms may occur because of the contamination itself or because of a safe reaction. Countless individuals worldwide are influenced by neurological dislocation. Alzheimer's sickness is the most widely recognized reason for dementia and may be seen upto 60– 70% of cases.

Track-8: Childhood Trauma and Dementia

Childhood trauma is can be called as serious adverse childhood experiences.  Children may go through a range of experiences that classify as psychological trauma, these might include neglect, abandonment, sexual abuse, and physical abuse. Traumatic experiences during childhood causes stress that increases an individual's chronic stress and thus affects the immune system. Childhood trauma is frequently associated with adverse health outcomes together with depressionhypertension, autoimmune diseases, lung cancer, and premature mortality. Childhood trauma shows its effects on brain development like emotional regulation and impairment of social development skills.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 05-06, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View